Slingshot members are tracking this event:
PDUFA date for Regeneron's (REGN) Praluent (alirocumab) (ODYSSEY OUTCOMES study) for Cardiovascular events due April 28, 2019.
Slingshot Insights Explained
Apr 26, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Praluent, Alirocumab, Odyssey, Cardiovascular Events